P.M. Wencyk
Impact in
- Cancer Research top 5%
- Breast Cancer Treatment Studies
- Oncology top 5%
- HER2/EGFR in Cancer Research
- Cancer Cells and Metastasis
- Cancer-related Molecular Pathways
Papers in
- Oncology 8
- HER2/EGFR in Cancer Research 5
-
- Wnt/β-catenin signaling in development and cancer 2
- Co-authors
- Ian O. Ellis (14 shared papers)JA Bell (4 shared papers)Robert I. Nicholson (3 shared papers)Joshua A. Bell (8 shared papers)CW Elston (3 shared papers)Sarah E. Pinder (5 shared papers)R.W. Blamey (5 shared papers)RW Blamey (2 shared papers)
- Journals
- The Journal of Pathology (4 papers)British Journal of Cancer (3 papers)European Journal of Cancer (3 papers)Cytopathology (1 paper)JNCI Journal of the National Cancer Institute (1 paper)
- Partner nations
- United Kingdom
In The Last Decade
P.M. Wencyk
15 papers receiving 890 citations
Peers
Comparison fields: 5 of 62
- Cancer Research 321
- Oncology 582
- Pathology and Forensic Medicine 187
- Radiology, Nuclear Medicine and Imaging 215
- Immunology and Allergy 40
Countries citing papers authored by P.M. Wencyk
This map shows the geographic impact of P.M. Wencyk's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by P.M. Wencyk with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites P.M. Wencyk more than expected).
Fields of papers citing papers by P.M. Wencyk
This network shows the impact of papers produced by P.M. Wencyk. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by P.M. Wencyk. The network helps show where P.M. Wencyk may publish in the future.
Co-authors
The 25 scholars most cited alongside P.M. Wencyk, linked wherever they have co-authored with each other. Click a name or a connecting line to browse the papers they share.
All Works
| # | Work | ||
|---|---|---|---|
| 1 | 2003 | 191 | |
| 2 | 1995 | 156 | |
| 3 | 2002 | 112 | |
| 4 | 1996 | 106 | |
| 5 | 1999 | 84 | |
| 6 | 2001 | 67 | |
| 7 | 2003 | 48 | |
| 8 | 1991 | 45 | |
| 9 | 2003 | 37 | |
| 10 | 1997 | 22 | |
| 11 | 2004 | 18 | |
| 12 | 1995 | 17 | |
| 13 | 2001 | 3 | |
| 14 | 2001 | 2 | |
| 15 | 2001 | 1 |
About P.M. Wencyk
P.M. Wencyk is a scholar working on Oncology, Molecular Biology, Cancer Research, Pathology and Forensic Medicine and Radiology, Nuclear Medicine and Imaging, having authored 15 papers that have together received 909 indexed citations. Recurring topics across this work include HER2/EGFR in Cancer Research (5 papers), Breast Cancer Treatment Studies (4 papers), Breast Lesions and Carcinomas (4 papers), Monoclonal and Polyclonal Antibodies Research (3 papers), Wnt/β-catenin signaling in development and cancer (2 papers), Neuroendocrine Tumor Research Advances (2 papers), BRCA gene mutations in cancer (2 papers) and Microtubule and mitosis dynamics (1 paper). The work is most often cited by research in Cancer Research (321 citations), Oncology (582 citations), Pathology and Forensic Medicine (187 citations), Radiology, Nuclear Medicine and Imaging (215 citations) and Immunology and Allergy (40 citations). P.M. Wencyk has collaborated with scholars based in United Kingdom. Frequent co-authors include Ian O. Ellis, JA Bell, Robert I. Nicholson, Joshua A. Bell, CW Elston, Sarah E. Pinder, R.W. Blamey, RW Blamey, JFR Robertson and S Pinder. Their work appears in journals such as The Journal of Pathology, British Journal of Cancer, European Journal of Cancer, Cytopathology and JNCI Journal of the National Cancer Institute.
Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.